My ePortfolio Register   

Cimavax - a lung cancer vaccine

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.01.17
Views: 1281

Dr Danay Saavedra - Centro de Inmunología Molecular, CIM, Cuba

Dr Saavedra speaks with ecancertv at the ecancer Colombian Cancer Congress about a novel anti-cancer vaccine, Cimavax.

She describes the immuno-targeting of the vaccine against EGF, and how blocking this pathway can halt cancer cell cycle progression.

Considering results from phase III studies, in treating advanced non-small cell lung cancer patients, Dr Saavedra reports a significant benefit for patients expression high levels of EGF.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence